the emerging continuum of care in metastatic kidney cancer in the second-line and beyond
Published 1 year ago • 189 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
0:54
advances in the development of targeted therapies for renal cell carcinoma
-
5:11
current treatment landscape for kidney cancer
-
4:15
the unmet needs of kidney cancer treatment
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
1:59
key objectives in kidney cancer: treatment sequencing & refining clinical endpoints
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
5:57
current landscape and future direction in systemic therapy for renal cell carcinoma (rcc)
-
5:16
potential new treatments in renal cell carcinoma
-
1:42
current treatment landscape in renal cell carcinoma
-
1:09
advancements in systemic therapy for kidney cancer: implications for treatment decision-making
-
4:49
frontline tki strategies in kidney cancer
-
1:48
what is the best second-line treatment of advanced renal cell carcinoma (rcc)?
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
0:59
updates in kidney cancer at esmo 2022
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
3:34
new strategies in kidney cancer
-
3:59
the future of renal cell carcinoma
-
6:34
kidney cancer – an introduction
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma